The patented Valve Less Fluidic Switching technology automates programmable flow switching and mixing for miniaturized bioassays without the need for mechanical microvalves or other integrated moving parts. This technology is employed in commercial platforms for automated immunoassays, spheroid assays, and organoid assays.